File:Warfarin.svg · Wikimedia Commons · See Wikimedia Commons
rac-warfarin
Sign in to saveAlso known as warfarin
Warfarin, sold under the brand name Coumadin among others, is used as an anticoagulant medication. It is commonly used to prevent deep vein thrombosis and pulmonary embolism, and to protect against stroke in people who have atrial fibrillation, valvular heart disease, or artificial heart valves. Warfarin may sometimes be prescribed following a ST-segment elevation myocardial infarction and orthopedic surgery. It is usually taken by mouth, but may also be administered intravenously.
Key facts
- Drug.Verifiedfields
- changed
- Drug.Watchedfields
- changed
- Drug.verifiedrevid
- 460939157
- Drug.image
- Warfarin.svg
- Drug.image_class
- skin-invert-image
- Drug.image_class2
- bg-transparent
- Drug.width
- 200
- Drug.image2
- Warfarin ball-and-stick model from xtal 2002.png
- Drug.width2
- 250
- Drug.tradename
- Coumadin, others
- Drug.MedlinePlus
- a682277
- Drug.DailyMedID
- Warfarin
- Drug.pregnancy_AU
- D
- Drug.routes_of_administration
- By mouth, intravenous
- Drug.ATC_prefix
- B01
- Drug.ATC_suffix
- AA03
- Drug.legal_AU
- S4
- Drug.legal_CA
- Rx-only
via Wikipedia infobox
Research
7 papers- Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects.British journal of clinical pharmacology · 2004
- The pharmacokinetics and pharmacodynamics of single dose (R)- and (S)-warfarin administered separately and together: relationship to VKORC1 genotype.British journal of clinical pharmacology · 2013
- Assessing the relative potency of (S)- and (R)-warfarin with a new PK-PD model, in relation to VKORC1 genotypes.European journal of clinical pharmacology · 2017
- Disposition of warfarin enantiomers and metabolites in patients during multiple dosing with rac-warfarin.British journal of clinical pharmacology · 1994
- Induced circular dichroism spectra reveal binding of the antiinflammatory curcumin to human alpha1-acid glycoprotein.Bioorganic & medicinal chemistry · 2004
via PubMed
Wikidata facts
Show 18 more facts
- significant drug interaction
- aprepitant
- solubility
- 22.2
- density
- 1.35
- melting point
- 162
- surface tension
- 72.8
- vapor pressure
- 0.09
- medical condition treated
- thrombosis
- World Health Organisation international non-proprietary name
- warfarin
- partition coefficient water/octanol
- 0.7
- pKa
- 5
- NIOSH Pocket Guide ID
- 0665
- time-weighted average exposure limit
- 0.1
- immediately dangerous to life or health
- 100
- defined daily dose
- 7.5
- route of administration
- intravenous injection
- subject has role
- essential medicine
- Commons category
- Warfarin
- legal status (medicine)
- boxed warning
Sources (8)
via Wikidata · CC0
~40 min read
Encyclopedic overview
35 sectionsContents
- Medical uses
- Dosing
- Maintenance dose
- Self-testing
- Alternative anticoagulants
- Contraindications
- Pregnancy
- First trimester of pregnancy
- Second trimester and later
- Adverse effects
- Bleeding
- Warfarin necrosis
- Osteoporosis
- Purple toe syndrome
- Calcification
- Overdose <span class="anchor" id="Reversal"></span>
- Interactions
- Chemistry
- Stereochemistry
- Pharmacology
- Pharmacokinetics
- Mechanism of action
- Pharmacogenomics
- History
- Occupational safety
- Society and culture
- Brand names
- Veterinary use
- Pest control
- Rodents
- Vampire bats
- Brand names
- References
- Further reading
- External links
Warfarin, sold under the brand name Coumadin among others, is used as an anticoagulant medication. It is commonly used to prevent deep vein thrombosis and pulmonary embolism, and to protect against stroke in people who have atrial fibrillation, valvular heart disease, or artificial heart valves. Warfarin may sometimes be prescribed following a ST-segment elevation myocardial infarction and orthopedic surgery. It is usually taken by mouth, but may also be administered intravenously.
The common side effect, a natural consequence of reduced clotting, is bleeding. Less common side effects may include areas of tissue damage, and purple toes syndrome. Use is not recommended during pregnancy. The effects of warfarin are typically monitored by checking prothrombin time (INR) every one to four weeks. Many other medications and dietary factors can interact with warfarin, either increasing or decreasing its effectiveness. The effects of warfarin may be reversed with phytomenadione (vitamin K1), fresh frozen plasma, or prothrombin complex concentrate.
Excerpted from Wikipedia’s “rac-warfarin” article, available under the CC BY-SA 4.0 licence.